Poirier Michael S. 4
4 · Qualigen Therapeutics, Inc. · Filed Aug 4, 2022
Insider Transaction Report
Form 4
Poirier Michael S.
DirectorChairman, President & CEO.
Transactions
- Award
Stock Option (Right to Buy)
2022-07-11+375,000→ 375,000 totalExercise: $0.51Exp: 2032-07-11→ Common Stock (375,000 underlying)
Footnotes (1)
- [F1]Shares underlying the stock option vest over three years in equal annual installments from the date of grant.